Priority Approval/Registration of Drugs Remdesivir and Tocilizumab During the COVID-19 pandemic Ijaz Mustafa COVID-19 June 15, 2020January 18, 2022 Priority-Approval_Registration-of-Drugs-Remdesivir-and-Tocilizumab-During-the-COVID-19-pandemicDownload Share this:TwitterFacebook
